Some epidemiologists are planning a second study to evaluate the PSA screening test. The only difference is that this time, the men from Reno who they randomly sample will be 44-59 years of age. Age is a strong risk factor for prostate cancer. The prevalence of prostate cancer in men 44-59 years of age will be much lower than the prevalence of prostate cancer in men 60-75 years of age. How do you expect the results of the second study will compare with the results from the study conducted among 60-75 year old men